MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Susan Galbraith
Susan GalbraithASTRAZENECA PLC

Susan Galbraith

Executive Vice President of Oncology R&D at ASTRAZENECA PLC

Manager

Deal Bio

Total Deals3
Valued Deals4
Total Value£ 2.01 B
Avg. Deal Size£ 502 M

Market Context

Sort

29 Nov 2022|Netherlands|Biotechnology
Neogene Therapeutics
Astrazeneca

Target: NEOGENE THERAPEUTICS

Bidder: ASTRAZENECA PLC

7 Service Providers

3 Target | 2 Bidder | 2 Vendor

60 Dealmakers

29 Target | 24 Bidder | 7 Vendor

£ 264 M

Value

26 Dec 2023|China|Biotechnology
Gracell Biotechnologies
Astrazeneca

Target: GRACELL BIOTECHNOLOGIES INC

Bidder: ASTRAZENECA PLC

11 Service Providers

7 Target | 4 Bidder

34 Dealmakers

18 Target | 16 Bidder

£ 971 M

Value

19 Mar 2024|Canada|Biotechnology
Fusion Pharmaceuticals
Astrazeneca

Target: FUSION PHARMACEUTICALS

Bidder: ASTRAZENECA PLC

8 Service Providers

5 Target | 3 Bidder

68 Dealmakers

35 Target | 33 Bidder

£ 1.57 B

Value

17 Mar 2025|Belgium|Biotechnology
ESOBIOTEC
Astrazeneca

Target: ESOBIOTEC

Bidder: ASTRAZENECA PLC

5 Service Providers

3 Target | 2 Bidder

28 Dealmakers

20 Target | 8 Bidder

£ 772 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Susan Galbraith